Sunshine Biopharma, Inc.
Sunshine Biopharma, Inc. (SBFM) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · SBFM · as of Mar 31, 2024
Ownership Breakdown
1
Institutional Holders
$1
Total Inst. Value
▼ $4 vs Q4
500,580
Shares Outstanding
freeFloat 99.37%
18
13F Shares Held
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
SBFM largest shareholders · institutional ownership
Q1 2024 · SEC 13F
Showing top 1 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
RISE ADVISORS, LLC services-commercial physical & biological research | 18 | 0.28% | 0.28% | $1,000 | Apr 9, 2024 | — held |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q1 2024 vs prior quarter
Q1 2024
0
Increased
+0 shares0
New Positions
first time holders0
Decreased
−0 shares0
Sold Out
fully exitedNet shares change (top 50)
+0
+0 / −0
Net new holders
+0
0 new / 0 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
SBFM insider trading · insider activity
Source: SEC Form 4
Insiders have been net buyers of shares recently. Selling may be driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment.
1
Buy transactions
0
Sell transactions
0.00
Buy/Sell ratio
$0M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
NATAN DAVID director | Apr 14, 2026 | Award | 100,000 | — | — | 100.0K | Form 4 ↗ |
Slilaty Steve N. Chief Executive Officer | Mar 4, 2024 | Purchase | 100,000 | $0.10 | $10.0K | 130.0K | Form 4 ↗ |
Slilaty Steve N. Chief Executive Officer | Feb 8, 2024 | Purchase | 20,000 | $0.10 | $2.0K | 30.0K | Form 4 ↗ |
Sebaaly Camille CFO/Secretary | Nov 30, 2022 | Purchase | 30,000 | $0.76 | $22.9K | 174.5K | Form 4 ↗ |
Sebaaly Camille CFO/Secretary | Jun 3, 2022 | Purchase | 25,000 | $1.22 | $30.5K | 144.5K | Form 4 ↗ |
Slilaty Steve N. Chief Executive Officer | Feb 18, 2022 | D-Return | 990,000 | $0.10 | $99.0K | 10.0K | Form 4 ↗ |
MERZOUKI ABDERRAZZAK Chief Operating Officer | Jan 6, 2021 | Award | 20,000,000 | $0.00 | $20.0K | 23.34M | Form 4 ↗ |
Slilaty Steve N. Chief Executive Officer | Jan 6, 2021 | Award | 20,000,000 | $0.00 | $20.0K | 23.34M | Form 4 ↗ |
Sebaaly Camille CFO/Secretary | Jan 6, 2021 | Award | 20,000,000 | $0.00 | $20.0K | 23.89M | Form 4 ↗ |
Sebaaly Camille CFO/Secretary | Dec 19, 2019 | Award | 1,300,000 | $0.00 | $1.3K | 3.89M | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
Sunshine Biopharma, Inc. (SBFM) is primarily owned by institutional investors, who hold approximately 0.0% of total shares outstanding. Company insiders own approximately 0.63%, while retail and public investors account for the remaining 99.37%.
The largest institutional shareholder of Sunshine Biopharma, Inc. is RISE ADVISORS, LLC, holding approximately 18 shares — equal to 0.28% of outstanding shares — as of March 31, 2024.
A total of 1 institutional investors currently hold SBFM stock, with a combined institutional value of approximately $1 as of the most recent 13F filing period.
Frequently asked questions
SBFM ownershipSunshine Biopharma, Inc. (SBFM) is primarily owned by institutional investors, who hold approximately 0.0% of shares. The largest shareholder is RISE ADVISORS, LLC with a 0.28% stake. Company insiders hold 0.63%. Data sourced from SEC Form 13F as of March 31, 2024.